A few weeks ago i posted the possibility NDTP could run to between $500 to $700 per share. I got some PM's saying that is wildly optimistic.
I agree. It is best case scenario in the intermediate run which is about 1 to 2 years.
But stay with me on this. At $500 per share and only 475,018 outstanding shares, that would value the company at $237,509,000. That is nothing for a nano tech pharmaceutical company with a product that could be on the cutting edge of brain trauma research.
Nano tech is very hot right now and getting hotter. In the coming years doctors will inject programmable nano bots into your system that will target cancer tumors, for instance. They will immediately head to the tumor and start to eat away at the cancer cells. Those devoured dead cells will then be carried by other nano bots straight to your bladder where they will exit your body through your urinary tract.
I was recently reading about this and it is fascinating. It is expected to revolutionize medical treatment bypassing many issues that are handled exclusively by invasive surgery currently.
News 
Market Data 
Discover 
AI
